Streptococcus pneumoniae infections - Current issues;Zakażenia streptococcus pneumoniae - Aktualne problemy

Postepy Mikrobiologii

Volumn 47, Issue 3, 2008, Pages 331-338

  Nowosiad, Monika ^a   Giedrys Kalemba, Stefania ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Prophylaxis; Resistance; Streptococcus pneumoniae infections

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; EVERNINOMICIN; KETOLIDE; LEVOFLOXACIN; MINOCYCLINE; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; DNA POLYMORPHISM; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; IMMUNITY; MINIMUM INHIBITORY CONCENTRATION; NASOPHARYNX; NONHUMAN; PHENOTYPE; PREVALENCE; REVIEW; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 69949123487     PISSN: 00794252     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Advisory Commitee on Immunization Practices: Preventing pneumococcal diseases among infants and young children. Recomendations of the Advisory Commitee on Immunisation Practices (ACIP). MMWR Recom. Rep. 49,1-35 (2000)
2. Alex Jacobs M.R., Felmingham D., Appelbaum P.C., Reuben N.G., Grünberg N., the Alexander Project Group: The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52, 229-246 (2003)
3. Alonso DeVelasco E., Verheul A.F., Verhoef J., Snippe H.: Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59, 591-603 (1995)
4. Appelbaum P.C.: Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15, 77-83 (1992)
5. Austrian R.: The Gram stain and the etiology of lobar pneumoniae, an historical note. Bacteriol. Rev. 24, 261-265 (1960)
6. Baquero F.: Trends in antibiotic resistance of respiratory pathogenes: an analysis and commentary on a collaborative surveillance study. J. Antimicrob. Chemoth. 38, Suppl. A: 117-132 (1996)
7. Bernatoniene J., Finn A.: Advances in pneumococcal vaccines-advanctages for infants and children. Drugs, 65, 229-256 (2005) (Pubitemid 40139384)
8. Boulnois G.J.: Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J. Gen. Microbiol. 138, 249-259 (1992)
9. Brooks-Walter A., Briles D.E., Hollingshead S.K.: The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteriemia. Infect. Immun. 67, 6533-6542 (1999)
10. Butler J.C., Breiman R.F., Campbell J.F., Lipman H.B., Broome C.V., Facklam R.R.: Pneumococcal vaccine efficacy. An evaluation of current recommendations. JAMA, 270, 1826-1831 (1993)
11. Butler J.B., Breiman R.F., Lipman H.B., Hofmann J., Facklam R.R.: Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States 1978-1994: implications for development of a conjugate vaccine. J. Infect. Dis. 171, 885-889 (1995)
12. Coffey T.J., Dowson C.G., Daniels M., Zhou J., Martin C., Spratt B.G., Musser J.M.: Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol. Microbiol. 5, 2255-2260 (1991)
13. Connell S.R., Tracz D.M., Nierhaus K.H., Taylor D.E.: Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob. Agents Chemother. 47, 3675-3681 (2003)
14. Depardieu F., Courvalin P.: Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45, 319-323 (2001)
15. Doherty N., Trzcinski K., Pickerill P., Zawadzki P., Dowson C.G.: Genetic diversity of the tet(M) gene in tetracycline resistant clonal lineages of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44, 2979-2984 (2000)
16. Dowson C.G., Barcus V., King S., Pickerill P., Whatmore A., Yeo M.: Horizontal gene transfer and the evolution of resistance and virulence determinants in Streptococcus. J. Appl. Microbiol. 83, 42-51 (1997)
17. Dzierżanowska D.: Antybiotykoterapia praktyczna. Bielsko-Biała, α-media press, 2000
18. Faden H., Duffy L., Wasielewski R., Wolf J., Krystofik D., Tung Y.: Relationship between nasopharyngeal colonization and the development of otitis media in children. J. Infect. Dis. 175, 1440-1445 (1997)
19. Fedson D.S.: Pneumococcal vaccine in the prevention of community-acquired pneumonia; an opimistic viev of cost-effectivens. Semi. Respir. Infect. 8, 285-293 (1993)
20. Feldman C., Klugman K.P.: Pneumococcal infections. Curr. Opin. Infect. Dis. 10, 109-115 (1997)
21. Goettsch W., Bronzwaer S.L., De Neeling A.J., Wale M.C., Aubry-Damon H., Olsson-Liljequist B.: Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus with the European Antimicrobial Resistance Surveillance System (EARSS). Clin. Microbiol. Infect. 6, 59-63 (2000)
22. Gray B.M., Converse G.M., Dillon H.C.: Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142, 923-933 (1980)
23. Greenwood B.: The epidemiology of pneumococcal infection in children in the developing world. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354, 777-785 (1999)
24. Grzesiowski P., Betlejemska K., Hryniewicz W.: Immunoprofilaktyka zakażeń Streptococcus pneumoniae wobec narastaja̧cej oporności na leki przeciwbakteryjne. Medycyna Zakażeń. Nowa Med. 9, 93 (1999)
25. th World Congress of thr World Society for Pediatric Infectious Disease, Warszawa, 2005, str. 87
26. Hakenbeck R., Kamiński K., Konig A., van der Linden M., Paik J., Reichmann P.: Penicillin-binding proteins in β-lactam-resistant Streptococcus pneumoniae. Microb. Drug Resist. 5, 91-99 (1999)
27. Hansman D., Bullen M.M.: A resistant pneumocoecus (letter). Lancet, 2, 264-265 (1967)
28. Hausdorf W.P., Bryant J., Paradiso P.R., Sieber G.R.: Which pneumococcal serogrups cause the most invasive disease: implications for conjugate formulation and use, part I. Clin. Infect. Dis. 30, 100-121 (2000)
29. Hausdorff W.P.: Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur. J. Pediatr. 16, 135-139 (2002)
30. Hausdorff W.P., Feikin D.R., Klugman K.P.: Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5, 83-93 (2005)
31. Hutchison B.G., Oxman A.D., Shannon H.S., Lloyd S., Altmayer C.A., Thomas K.: Clinical effectiveness of pneumococcal vaccine meta-analysis. Can. Fam. Phisician, 45, 2381-2393 (1999)
32. Jacobs M.R., Koornhof H.J., Robins-Browne R.M., Stevenson C.M., Vermaak Z.A., Freiman I.: Emergence of multiply resistant pneumococci. N. Engl. J. Med. 299, 735-740 (1978)
33. Jacobs M.R., Johnson C.E.: Macrolide resistace: an increasing concern for treatment failure in children. Ped. Infect. Dis. J. 22, 131-138 (2003)
34. Jedrzejas M.J.: Pneumococcal virulence factors: structure and function. Microbiol. Mol. Biol. Rev. 65, 187-207 (2001)
35. Kaplan S.L., Mason Jr E.O., Wald E.R., Schutze G.E., Bradley J.S., Tan T.Q.: Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics, 113, 443-449 (2004)
36. Kislak J.W., Razavi L.M.B., Daly A.K., Finland M.: Susceptibility of pneumococci to nine antibiotics. Am. J. Med. 250, 261-268 (1965)
37. Klugman K.P.: Pneumococcal Resistance to Antibiotics. Clin. Microbiol. Rev. 3, 171-196 (1990)
38. Klugman K.P.: Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect. Dis. 1, 85-91 (2001)
39. Kristinsson K.G.: Effect of antimicrobial use and other risk factor on antimicrobial resistance in pneumococci. Microb. Drug Resist. 3, 117-123 (1997)
40. Lund E., Henrichsen J.: Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. Methods Microbiol. 12, 241-262 (1978)
41. Markiewicz Z., Tomasz A.: Variation in pennicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci. J. Clin. Microb. 27, 445-465 (1989)
42. McGee L., McDougal L., Zhou J., Spratt B.G., Tenover F.C., George R.: Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae definied by the Pneumococcal Molecular Epidemiology Network. J. Clin. Microbiol. 39, 2565-2571 (2001)
43. Meats E., Brueggemann A.B., Enright M.C., Sleeman K., Griffiths D.T., Crook D.W.: Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J. Clin. Microbiol. 41, 386-392 (2003)
44. Musher D.M.: Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clin. Infect. Dis. 14, 801-807 (1992)
45. Nava J.M., Bella F., Garau J., Lite J., Morera M.A., Martí C.: Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: apopulation-based study. Clin. Infect. Dis. 19, 884-990 (1994)
46. Overweg K., Hermans P.W.M., Trzcinski K., Sluijter M., de Groot R., Hryniewicz W.: Multidrug-resistant Streptococcus pneumoniae in Poland: identification of emerging clones. J. Clin. Microbiol. 37, 1739-1745 (1999)
47. Raymond J., Le Thomas I., Moulin F., Commeau A., Gendrel D., Berche P.: Sequential colonization by Streptococcus pneumoniae of healthy children living in an orphanage. J. Infect. Dis. 181, 1983-1988 (2000)
48. Roberts M.C., Sutcliffe J., Courvalin P., Jensen L.B., Rood J., Seppälä H.: Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43, 2823-2830 (1999)
49. Rosenow C., Ryan P., Weiser J.N., Johnson S., Fontan P., Ortqvist A.: Contribution of novel choline-binding proteins to adherence, colonisation and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25, 819-829 (1997)
50. Schrag S.J., Beall B., Dowell S.F.: Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin. Microbiol. Rev. 13, 588-601 (2000)
51. Semczuk K., Łopaciuk U., Dzierżanowska-Fangrat K., Gabińska E., Dmeńska H., Dzierżanowska D.: Analiza wrażliwości Streptococcus pneumoniae, Haemophilus influenzae i Moraxella catarrhalis wyodrȩbnionych z materiałów klinicznych od dzieci z zakażeniami dróg oddechowych leczonych w IP-CZD w latach 1999-2002. Pediatr. Pol. 78, 173-180 (2003)
52. Skoczyńska A., Kadłubowski M., Hryniewicz W.: Inwazyjna choroba meningokokokowa i inne bakteryjne zakażenia ośrodkowego układu nerwowego - zasady postȩpowania. Przew. Lek. 8, 28-30 (2005)
53. Tomasz A.: The the role autolisins in cell death. Ann. N.Y. Acad. Sci. 235, 439-447 (1974)
54. Trzciński K., Hryniewicz W., Grupa robocza Projektu Aleksander: Antimicrobial susceptibility of common bacterial pathogens isolated from lower respiratory tract infections in Poland in 1996 - the Alexander Project. Med. Sci. Monit. 3, 714-722 (1997)
55. Whitney C.G., Barley M.M., Handler J.: Decline in invasive pneumococcal diseease after the introduction of protein-polysaccharyde cojugate vaccine. N. Eng. J. Med. 349, 715-716 (2003)